Carol  Burt net worth and biography

Carol Burt Biography and Net Worth

Director of ResMed
Carol Burt has served as a ResMed director since November 2013 and is chair of the audit and compliance oversight committees. She is also a member of the nominating and governance committee.


Ms. Burt, principal of Burt-Hilliard Investments is a private investor with more than 35 years experience in corporate governance, operations, strategy, finance, mergers and acquisition and investment banking. Since 2013, Ms. Burt has served as a senior advisor and a member of the operating council of Consonance Capital Partners, a New York-based private equity firm focused on investments in the healthcare industry. Ms. Burt serves on the boards of IQVIA Holdings Inc. (NYSE: IQV), where she is a member of the audit committee and leadership development and compensation committee; and two private companies, Global Medical Response and WellDyne.


Prior to their sale, Ms. Burt served on the public boards of Envision Healthcare, Transitional Hospitals, Vanguard Health Systems, WellCare Health Plans, and private-equity-backed KEPRO.


Ms. Burt was formerly senior vice president corporate finance and development of WellPoint, Inc. (now Anthem, Inc.) where she was part of the executive team that built WellPoint from a single state health plan to one of the leading health benefits companies in the US. Ms. Burt was responsible for, among other things, corporate strategic planning and execution, mergers and acquisitions, strategic and venture investments, financial reporting, budgeting and forecasting, treasury, business information systems and real estate management. In addition, WellPoint’s financial services and international insurance business units reported to her.


Before WellPoint, Ms. Burt was senior vice president and treasurer of American Medical Response. Previously, she spent 16 years at Chase Securities, Inc., now JP Morgan Chase & Co (NYSE: JPM), most recently as founder, managing director and head of the Health Care Banking Group.


Ms. Burt is a member of Women Corporate Directors and the International Women’s Forum. Her philanthropic activities focus on mentoring women for leadership positions and environmental causes.


Ms. Burt graduated magna cum laude from the University of Houston, earning a Bachelor of Business Administration.


Ms. Burt’s executive management and board experience in the health insurance, healthcare services, medical technology and financial services industries led the board to the conclusion that she should serve as a director.

What is Carol Burt's net worth?

The estimated net worth of Carol Burt is at least $1.50 million as of May 8th, 2017. Ms. Burt owns 8,447 shares of ResMed stock worth more than $1,500,272 as of April 19th. This net worth approximation does not reflect any other investments that Ms. Burt may own. Learn More about Carol Burt's net worth.

How do I contact Carol Burt?

The corporate mailing address for Ms. Burt and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on Carol Burt's contact information.

Has Carol Burt been buying or selling shares of ResMed?

Carol Burt has not been actively trading shares of ResMed within the last three months. Most recently, Carol Burt sold 1,500 shares of the business's stock in a transaction on Monday, November 22nd. The shares were sold at an average price of $260.00, for a transaction totalling $390,000.00. Learn More on Carol Burt's trading history.

Who are ResMed's active insiders?

ResMed's insider roster includes Carol Burt (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.

Are insiders buying or selling shares of ResMed?

In the last twelve months, insiders at the medical equipment provider sold shares 26 times. They sold a total of 69,970 shares worth more than $13,420,582.02. The most recent insider tranaction occured on March, 4th when General Counsel Michael J Rider sold 81 shares worth more than $14,580.00. Insiders at ResMed own 1.2% of the company. Learn More about insider trades at ResMed.

Information on this page was last updated on 3/4/2024.

Carol Burt Insider Trading History at ResMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Sell1,500$260.00$390,000.00View SEC Filing Icon  
11/15/2021Sell1,187$270.80$321,439.60View SEC Filing Icon  
See Full Table

Carol Burt Buying and Selling Activity at ResMed

This chart shows Carol Burt's buying and selling at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ResMed Company Overview

ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $177.61
Low: $176.33
High: $179.80

50 Day Range

MA: $186.29
Low: $173.72
High: $198.04

2 Week Range

Now: $177.61
Low: $132.24
High: $243.52

Volume

1,582,460 shs

Average Volume

1,001,381 shs

Market Capitalization

$26.12 billion

P/E Ratio

29.36

Dividend Yield

1.10%

Beta

0.67